Identification |
Identification |
Identification |
Lipid-lowering medication (statin) used for
primary prevention (performance gap) |
Introducing law on banning
e-cigarettes smoking (opportunity) |
New home glucose monitoring program
for diabetic patents (opportunity) |
Pre-marital genetic disease
screening (performance gap) |
Development
|
Development
|
Development
|
Determine multiple possible decisions using either:
Search
1. Ready-made. For example, from research studies, Clinical Practice
Guidelines, protocols, policy, or other sources
Search and design (innovate)
2. Custom-made. For example, by task force, team discussions, experts’
or leaders’ opinions, or individually built options
|
Determine multiple possible decisions using either:
Search
1. Ready-made. For example, from research studies, Clinical Practice
Guidelines, protocols, policy, or other sources
Search and design (innovate)
2. Custom-made. For example, by task force, team discussions, experts’
or leaders’ opinions, or individually built options
|
Determine multiple possible decisions using either:
Search
1. Ready-made. For example, from research studies, Clinical Practice
Guidelines, protocols, policy, or other sources
Search and design (innovate)
2. Custom-made. For example, by task force, team discussions, experts’
or leaders’ opinions, or individually built options
|
Determine multiple possible decisions using either:
Search
1. Ready-made. For example, from research studies, Clinical Practice
Guidelines, protocols, policy, or other sources
Search and design (innovate)
2. Custom-made. For example, by task force, team discussions, experts’
or leaders’ opinions, or individually built options
|
Evaluation
|
Rationalize: (Analysis and bargaining)
|
Benefit
|
Decrease in cardiovascular (CVD) outcomes
|
Decrease in smoking, increase in community awareness
|
Decrease in hypoglycemia, better control, better CVD outcomes
|
Decrease in hereditary diseases
|
|
|
Harm
|
Evidence of reported and unreported harm
|
Economic impact.
|
Worse quality of life with frequent testing
|
Worse quality of life due to anxiety over tests results of uncertain
significance, and risk of immediate decisions due to fear of
consequences of positive results
|
|
|
Cost
|
High
|
Cost saving (decreases in smoking prevalence and related diseases)
|
High
|
High
|
|
|
Patient Experience:
|
Side effects acceptance, preventive proactive attitude
|
Community acceptance due to perception of coercion and affected patient
autonomy
|
Variable either favorable or not.
|
Community acceptance due to perception of coercion and affected patient
autonomy
|
|
Validation:
|
Validation:
|
To consider age, conditions’ severity, ethnicity, socio-economic state,
Long- and short-term outcomes
|
To consider cultural and health long- and short-term outcomes
|
To consider diabetes control status, health literacy, age, medication
type,
long- and short-term outcomes.
|
To consider genetic diseases’ epidemiology, socio-economic state, health
literacy,
long- and short-term outcomes
|
|
Judgment and decision-making |
Judgment and
decision-making |
Judgment and decision-making |
Judgment and decision-making |
Judgment and
decision-making |
Judgment and decision-making |